期刊
JOURNAL OF IMMUNOLOGY
卷 182, 期 6, 页码 3556-3565出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.0802972
关键词
-
类别
资金
- National Health and Medical Research Council [351439, 508927]
- Princess Alexandra Hospital Foundation
- Arthritis Queensland
- Queensland Government Smart State Fellowships
- National Health and Research Council Career Development Award
Existing therapies for rheumatoid arthritis and other autoimmune diseases are not Ag specific, which increases the likelihood of systemic toxicity. We show that egg phosphatidylcholine liposomes loaded with Ag (OVA or methylated BSA) and a lipophilic NF-kappa B inhibitor (curcumin, quercetin, or Bay11-7082) suppress preexisting immune responses in an Ag-specific manner. We injected loaded liposomes into mice primed with Ag or into mice suffering from Ag-induced inflammatory arthritis. The liposomes targeted APCs in situ, suppressing the cells' responsiveness to NF-kappa B and inducing Ag-specific FoxP3(+) regulatory T cells. This regulatory mechanism suppressed effector T cell responses and the clinical signs of full-blown Ag-induced arthritis. Thus, liposomes encapsulate Ags and NF-kappa B inhibitors stably and efficiently and could be readily adapted to deliver Ags and inhibitors for Ag-specific suppression of other autoimmune and allergic diseases. The Journal of Immunology, 2009, 182: 3556-3565.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据